Literature DB >> 23231056

Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa.

Y Xu, X Zhang, Y Zhao, L Zhao, H Qiu, D Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23231056     DOI： 10.1111/hae.12070

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  4 in total

1.  Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A: A retrospective 6 case series.

Authors:  Lin-Yue Wang; Yan Shen; Han-Qing Zeng; Ying Zhang; Shi-Feng Lou; Jian-Chuan Deng; Yun Luo
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

Review 2.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

3.  International recommendations on the diagnosis and treatment of acquired hemophilia A.

Authors:  Andreas Tiede; Peter Collins; Paul Knoebl; Jerome Teitel; Craig Kessler; Midori Shima; Giovanni Di Minno; Roseline d'Oiron; Peter Salaj; Victor Jiménez-Yuste; Angela Huth-Kühne; Paul Giangrande
Journal:  Haematologica       Date:  2020-05-07       Impact factor: 9.941

4.  The treatment of acquired hemophilia with combination therapy of immunosuppressives and immunoadsorption.

Authors:  Aynur Uğur Bilgin; Muhit Ozcan; Erol Ayyıldız; Osman Ilhan
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.